A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

Clinical trial NCT01006122 · COMPLETED

Trial details

NCT number: NCT01006122
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Excessive Daytime Sleepiness Narcolepsy

Start date: 2009-11-01
Primary completion: 2010-11-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.